These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 9116635
1. Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein. Tarar MR, Emery VC, Harrison TJ. FEMS Immunol Med Microbiol; 1996 Dec 31; 16(3-4):183-92. PubMed ID: 9116635 [Abstract] [Full Text] [Related]
2. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. Schödel F, Moriarty AM, Peterson DL, Zheng JA, Hughes JL, Will H, Leturcq DJ, McGee JS, Milich DR. J Virol; 1992 Jan 31; 66(1):106-14. PubMed ID: 1370083 [Abstract] [Full Text] [Related]
3. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes. Schödel F, Peterson D, Hughes J, Wirtz R, Milich D. J Biotechnol; 1996 Jan 26; 44(1-3):91-6. PubMed ID: 8717391 [Abstract] [Full Text] [Related]
4. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination. Schödel F, Peterson D, Hughes J, Milich DR. Vaccine; 1993 Jan 26; 11(2):143-8. PubMed ID: 7679864 [Abstract] [Full Text] [Related]
5. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety. Schödel F, Peterson D, Milich D. Intervirology; 1996 Jan 26; 39(1-2):104-10. PubMed ID: 8957676 [Abstract] [Full Text] [Related]
6. Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. Brown AL, Francis MJ, Hastings GZ, Parry NR, Barnett PV, Rowlands DJ, Clarke BE. Vaccine; 1991 Aug 26; 9(8):595-601. PubMed ID: 1722937 [Abstract] [Full Text] [Related]
7. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits. Isaguliants MG, Kadoshnikov YP, Kalinina TI, Smirnov VD, Wahren B. Biochemistry (Mosc); 1998 May 26; 63(5):551-8. PubMed ID: 9632891 [Abstract] [Full Text] [Related]
9. Comparative immunogenicity of hepatitis B virus core and E antigens. Milich DR, McLachlan A, Stahl S, Wingfield P, Thornton GB, Hughes JL, Jones JE. J Immunol; 1988 Nov 15; 141(10):3617-24. PubMed ID: 2460543 [Abstract] [Full Text] [Related]
10. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions. Kazaks A, Lachmann S, Koletzki D, Petrovskis I, Dislers A, Ose V, Skrastina D, Gelderblom HR, Lundkvist A, Meisel H, Borisova G, Krüger DH, Pumpens P, Ulrich R. Intervirology; 2002 Nov 15; 45(4-6):340-9. PubMed ID: 12602354 [Abstract] [Full Text] [Related]
11. The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope. Meyer H, Masuho Y, Mach M. J Gen Virol; 1990 Oct 15; 71 ( Pt 10)():2443-50. PubMed ID: 1700066 [Abstract] [Full Text] [Related]
12. Construction of prokaryotic expression system of TGF-beta1 epitope gene and identification of recombinant fusion protein immunity. Guo YH, Hao ZM, Luo JY, Wang JH. World J Gastroenterol; 2005 Oct 28; 11(40):6389-94. PubMed ID: 16419171 [Abstract] [Full Text] [Related]
13. Phage displayed HBV core antigen with immunogenic activity. Bahadir AO, Balcioglu BK, Uzyol KS, Hatipoglu I, Sogut I, Basalp A, Erdag B. Appl Biochem Biotechnol; 2011 Dec 28; 165(7-8):1437-47. PubMed ID: 21915589 [Abstract] [Full Text] [Related]
14. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus. Nemecková S, Sroller V, Kunke D, Krystofová J, Kutinová L. Acta Virol; 1996 Dec 28; 40(5-6):273-9. PubMed ID: 9171455 [Abstract] [Full Text] [Related]
15. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo. Zhang Y, Song S, Liu C, Wang Y, Xian X, He Y, Wang J, Liu F, Sun S. Cell Immunol; 2007 May 28; 247(1):18-27. PubMed ID: 17707782 [Abstract] [Full Text] [Related]
16. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines. Schödel F, Kelly SM, Peterson D, Milich D, Hughes J, Tinge S, Wirtz R, Curtiss R. Dev Biol Stand; 1994 May 28; 82():151-8. PubMed ID: 7958469 [Abstract] [Full Text] [Related]
17. Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface. Borisova GP, Berzins I, Pushko PM, Pumpen P, Gren EJ, Tsibinogin VV, Loseva V, Ose V, Ulrich R, Siakkou H. FEBS Lett; 1989 Dec 18; 259(1):121-4. PubMed ID: 2480917 [Abstract] [Full Text] [Related]
18. Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals. Ayata M, Sugano T, Murayama T, Sakamuro D, Takegami T, Matsumoto Y, Furukawa T. J Med Virol; 1994 Aug 18; 43(4):386-92. PubMed ID: 7525866 [Abstract] [Full Text] [Related]
19. Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties. Beesley KM, Francis MJ, Clarke BE, Beesley JE, Dopping-Hepenstal PJ, Clare JJ, Brown F, Romanos MA. Biotechnology (N Y); 1990 Jul 18; 8(7):644-9. PubMed ID: 1369994 [Abstract] [Full Text] [Related]
20. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. Ohlin M, Sundqvist VA, Mach M, Wahren B, Borrebaeck CA. J Virol; 1993 Feb 18; 67(2):703-10. PubMed ID: 7678304 [Abstract] [Full Text] [Related] Page: [Next] [New Search]